Madrigal Pharmaceuticals (MDGL) Change in Inventory (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has 3 years of Change in Inventory data on file, last reported at $22.2 million in Q1 2026.

• On a quarterly basis, Change in Inventory rose 4.79% year-over-year to $22.2 million in Q1 2026; TTM through Mar 2026 was $38.0 million, a 30.15% decrease from a year earlier, with the FY2025 full-year figure at $37.0 million, up 8.54% from the prior year.
• Change in Inventory for Q1 2026 stood at $22.2 million, up from $1.7 million in the prior quarter.
• Over the last five years, Change in Inventory for MDGL reached as high as $25.4 million in Q4 2024 and fell as low as $854000.0 in Q1 2024.
• Historically, Change in Inventory has averaged $10.4 million across 3 years, with a median of $6.2 million in 2024.
• On a YoY basis, Change in Inventory climbed as much as 2379.27% in 2025 and fell as far as 93.18% in 2025.
• Year by year, Change in Inventory stood at $25.4 million in 2024, then plunged by 93.18% to $1.7 million in 2025, then jumped by 1183.23% to $22.2 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $22.2 million in Q1 2026, $1.7 million in Q4 2025, and $5.8 million in Q3 2025.